Interleukin 17 deficiency and implications in cutaneous and systemic diseases

Amarilyo, 2014, IL-17 promotes murine lupus, J. Immunol., 193, 540, 10.4049/jimmunol.1400931 Bai, 2009, IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function, J. Immunol., 183, 5886, 10.4049/jimmunol.0901584 Bar, 2014, IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells, Immunity, 40, 117, 10.1016/j.immuni.2013.12.002 Burakoff, 2006, A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn’s disease, Inflamm. Bowel Dis., 12, 558, 10.1097/01.ibd.0000225337.14356.31 Bush, 2002, Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein, Arthritis Rheum., 46, 802, 10.1002/art.10173 Chiricozzi, 2013, IL-17 targeted therapies for psoriasis, Expert Opin. Investig. Drugs, 22, 993, 10.1517/13543784.2013.806483 Cho, 2010, IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice, J. Clin. Invest., 120, 1762, 10.1172/JCI40891 Curtis, 2009, Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens, Immunology, 126, 177, 10.1111/j.1365-2567.2008.03017.x Cypowyj, 2012, Immunity to infection in IL-17-deficient mice and humans, Eur. J. Immunol., 42, 2246, 10.1002/eji.201242605 Danzaki, 2012, Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice, Arterioscler. Thromb. Vasc. Biol., 32, 273, 10.1161/ATVBAHA.111.229997 Doreau, 2009, Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus, Nat. Immunol., 10, 778, 10.1038/ni.1741 Elson, 2007, Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice, Gastroenterology, 132, 2359, 10.1053/j.gastro.2007.03.104 Gao, 2010, A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice, J. Immunol., 185, 5820, 10.4049/jimmunol.1000116 Gladiator, 2013, Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection, J. Immunol., 190, 521, 10.4049/jimmunol.1202924 Gopal, 2014, Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection, PLoS Pathog., 10, e1004099, 10.1371/journal.ppat.1004099 He, 2009, IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses, J. Immunol., 183, 1463, 10.4049/jimmunol.0804108 He, 2010, IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells, J. Immunol., 184, 2281, 10.4049/jimmunol.0902574 Huppler, 2012, Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy, Arthritis Res. Ther., 14, 217, 10.1186/ar3893 Imamura, 2009, Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung, Thorax, 64, 44, 10.1136/thx.2007.094540 Ishigame, 2009, Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses, Immunity, 30, 108, 10.1016/j.immuni.2008.11.009 Jin, 2013, IL-17 cytokines in immunity and inflammation, Emerg. Microb. Infect., 10.1038/emi.2013.58 Kagami, 2010, IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans, J. Immunol., 185, 5453, 10.4049/jimmunol.1001153 Kellner, 2013, Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential, Ther. Adv. Musculoskelet. Dis., 5, 141, 10.1177/1759720X13485328 Kotake, 1999, IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis, J. Clin. Invest., 103, 1345, 10.1172/JCI5703 Kryczek, 2009, Endogenous IL-17 contributes to reduced tumor growth and metastasis, Blood, 114, 357, 10.1182/blood-2008-09-177360 Liu, 2011, Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis, J. Exp. Med., 208, 1635, 10.1084/jem.20110958 Lubberts, 2004, Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion, Arthritis Rheum., 50, 650, 10.1002/art.20001 Ma, 2008, Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3, J. Exp. Med., 205, 1551, 10.1084/jem.20080218 Madhur, 2011, Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice, Arterioscler. Thromb. Vasc. Biol., 31, 1565, 10.1161/ATVBAHA.111.227629 Moutsopoulos, 2014, Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss, Sci. Transl. Med., 6, 229ra40, 10.1126/scitranslmed.3007696 Nakae, 2002, Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses, Immunity, 17, 375, 10.1016/S1074-7613(02)00391-6 Nakajima, 2014, IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models, J. Invest. Dermatol., 134, 2122, 10.1038/jid.2014.51 Nielsen, 2003, Upregulation of interleukin-12 and -17 in active inflammatory bowel disease, Scand. J. Gastroenterol., 38, 180, 10.1080/00365520310000672 Paulson, 2008, Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3, Curr. Opin. Allergy Clin. Immunol., 8, 527, 10.1097/ACI.0b013e3283184210 Peiser, 2013, Role of Th17 cells in skin inflammation of allergic contact dermatitis, Clin. Dev. Immunol., 2013, 261037, 10.1155/2013/261037 Plater-Zyberk, 2009, Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model, Ann. Rheum. Dis., 68, 721, 10.1136/ard.2007.085431 Raychaudhuri, 2013, Role of IL-17 in psoriasis and psoriatic arthritis, Clin. Rev. Allergy Immunol., 44, 183, 10.1007/s12016-012-8307-1 Sillevis Smitt, 2013, Cutaneous manifestations of primary immunodeficiency, Curr. Opin. Pediatr., 25, 492, 10.1097/MOP.0b013e3283623b9f Stark, 2005, Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17, Immunity, 22, 285, 10.1016/j.immuni.2005.01.011 Tong, 2012, A protective role by interleukin-17F in colon tumorigenesis, PLoS ONE, 7, e34959, 10.1371/journal.pone.0034959 Wareham, 2014, Evidence for a role for interleukin-17, Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaques, PLoS ONE, 9, e88149, 10.1371/journal.pone.0088149 Wen, 2013, Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA, PLoS ONE, 8, e58161, 10.1371/journal.pone.0058161 Wu, 2009, A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses, Nat. Med., 15, 1016, 10.1038/nm.2015 Yamada, 2010, Current perspectives on the role of IL-17 in autoimmune disease, J. Inflamm. Res., 3, 33, 10.2147/JIR.S6375 Ye, 2001, Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense, J. Exp. Med., 194, 519, 10.1084/jem.194.4.519 Yen, 2006, IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6, J. Clin. Invest., 116, 1310, 10.1172/JCI21404